9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Berardinelli-Seip syndrome is a rare congenital lipoatrophy with a severe prognosis and no efficient therapy. Children present with low leptin levels and severe metabolic complications (insulin resistance, elevated triglyceride levels, and hepatic steatosis). The objective of this study was to test safety and efficacy of recombinant-methionyl-human leptin replacement in children with Berardinelli-Seip syndrome before development of severe metabolic disease

          Related collections

          Author and article information

          Journal
          Pediatrics
          Pediatrics
          American Academy of Pediatrics (AAP)
          1098-4275
          0031-4005
          Aug 2007
          : 120
          : 2
          Affiliations
          [1 ] Université Paris 7, INSERM U690, Paris, France. jacques.beltrand@rdebre.inserm.fr
          Article
          120/2/e291
          10.1542/peds.2006-3165
          17671040
          a9f64351-f947-4ad8-a745-a4f37a3d0655
          History

          Comments

          Comment on this article